Abstract 1001: Leveraging Electronic Health Records to examine the real-world rates of cancer genetics referrals in a Singapore healthcare cluster

Abstract Identifying patients with hereditary cancer syndromes through genetics referral enhances early detection and reduces healthcare costs. Despite potential benefits, genetics referral rates globally, including Singapore, remain low. This study investigates the real-world rates of genetics referrals in eligible cancer patients at Singapore’s largest healthcare cluster using Electronic Health Records. Referral criteria for genetics referrals were based on international guidelines. The institution’s data repository was queried for eligible patients with relevant diagnosis codes from 2017 to 2021. We assessed genetics clinic attendance among eligible patients to evaluate referral rates. Variations in referral rates over time were analyzed using linear regression and two-tailed t-test. Of the 10080 patients eligible for a genetics referral, 17.1% (1719) were referred to a cancer genetics clinic. Breast, ovarian, colorectal, and endometrial cancers accounted for 42.9%, 33.5%, 11.3%, and 8.6% of referrals, respectively. Other tumor types accounted for 3.7% of referrals. Referral rates for suspected Hereditary Breast and Ovarian Cancer syndrome (HBOC)-related cancers were higher (19.7%) than referrals for suspected Lynch syndrome (12.2%). Among HBOC referrals, women (20.7%) were more likely to be referred than males (7.8%). From 2017 to 2021, the referral rates among eligible patients steadily increased from 11.6% (483/4174) in 2017 to 23.6% (403/1705) in 2021, an increase of 12%, p=0.005. From 2017 to 2021, we found an increase in referral rates for HBOC (12.8% to 28.6 %, p= 0.005) but not for Lynch syndrome-related indications (8% to 12.6%, p=NS). The increase in referral rates for suspected HBOC in women was more significant than in men (p=0.03) This study found lower referral rates for Lynch syndrome than HBOC, and identified a gender discrepancy, with men with HBOC being less likely to be referred. Efforts to increase referral rates should include raising clinician awareness and electronically identifying suspected cases, especially for male breast cancer and Lynch Syndrome. Citation Format: Jonathan Jian Hao Soon, Jianglei Wu, Nur Diana Binte Ishak, See Wei Qiang, Hing Pong Matthew Che, Michael Dorosan, Jeanette Yuen, Andrea Wan Ling Tan, Marcus Eng Hock Ong, Sean Shao Wei Lam, Hwee Lin Wee, Jianbang Chiang, Joanne Ngeow. Leveraging Electronic Health Records to examine the real-world rates of cancer genetics referrals in a Singapore healthcare cluster [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1001.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-1001
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1001: Leveraging Electronic Health Records to examine the real-world rates of cancer genetics referrals in a Singapore healthcare cluster

Shao Wei Lam, Jianbang Chiang, Jonathan Jian Hao Soon, Jeanette Yuen et al.
Cancer Research
BRCA gene mutations in cancer
article

Abstract 1001: Leveraging Electronic Health Records to examine the real-world rates of cancer genetics referrals in a Singapore healthcare cluster

Shao Wei Lam, Jianbang Chiang, Jonathan Jian Hao Soon, Jeanette Yuen, A.C. Tan, Jaw‐Ching Wu, Nur Diana Binte Ishak, H. Samore Matthew, Michael Dorosan, Hwee Lin Wee, Joanne Ngeow, Marcus Eng Hock Ong, Sheng Qiang
article en

Abstract

Abstract Identifying patients with hereditary cancer syndromes through genetics referral enhances early detection and reduces healthcare costs. Despite potential benefits, genetics referral rates globally, including Singapore, remain low. This study investigates the real-world rates of genetics referrals in eligible cancer patients at Singapore’s largest healthcare cluster using Electronic Health Records. Referral criteria for genetics referrals were based on international guidelines. The institution’s data repository was queried for eligible patients with relevant diagnosis codes from 2017 to 2021. We assessed genetics clinic attendance among eligible patients to evaluate referral rates. Variations in referral rates over time were analyzed using linear regression and two-tailed t-test. Of the 10080 patients eligible for a genetics referral, 17.1% (1719) were referred to a cancer genetics clinic. Breast, ovarian, colorectal, and endometrial cancers accounted for 42.9%, 33.5%, 11.3%, and 8.6% of referrals, respectively. Other tumor types accounted for 3.7% of referrals. Referral rates for suspected Hereditary Breast and Ovarian Cancer syndrome (HBOC)-related cancers were higher (19.7%) than referrals for suspected Lynch syndrome (12.2%). Among HBOC referrals, women (20.7%) were more likely to be referred than males (7.8%). From 2017 to 2021, the referral rates among eligible patients steadily increased from 11.6% (483/4174) in 2017 to 23.6% (403/1705) in 2021, an increase of 12%, p=0.005. From 2017 to 2021, we found an increase in referral rates for HBOC (12.8% to 28.6 %, p= 0.005) but not for Lynch syndrome-related indications (8% to 12.6%, p=NS). The increase in referral rates for suspected HBOC in women was more significant than in men (p=0.03) This study found lower referral rates for Lynch syndrome than HBOC, and identified a gender discrepancy, with men with HBOC being less likely to be referred. Efforts to increase referral rates should include raising clinician awareness and electronically identifying suspected cases, especially for male breast cancer and Lynch Syndrome. Citation Format: Jonathan Jian Hao Soon, Jianglei Wu, Nur Diana Binte Ishak, See Wei Qiang, Hing Pong Matthew Che, Michael Dorosan, Jeanette Yuen, Andrea Wan Ling Tan, Marcus Eng Hock Ong, Sean Shao Wei Lam, Hwee Lin Wee, Jianbang Chiang, Joanne Ngeow. Leveraging Electronic Health Records to examine the real-world rates of cancer genetics referrals in a Singapore healthcare cluster [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1001.

Cancer ResearchVol. 85(8_Supplement_1)
National University of Singapore (SG), Duke-NUS Medical School (SG), National Cancer Centre Singapore (SG)
Openalex Percentile: Top 90%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.